Logo image of AVBP

ARRIVENT BIOPHARMA INC (AVBP) Stock Analyst Earnings Estimates

NASDAQ:AVBP - Nasdaq - US04272N1028 - Common Stock - Currency: USD

27.07  -0.32 (-1.17%)

After market: 27.07 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
AVBP revenue by date.AVBP revenue by date.
N/AN/AN/AN/A
1,386.92%		N/A
85.95%		N/A
64.73%		N/A
30.69%		N/A
24.70%		N/A
12.47%
EBITDA
YoY % growth
AVBP ebitda by date.AVBP ebitda by date.
N/AN/AN/AN/A
-32.29%		N/A
-29.99%		N/A
-36.59%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AVBP ebit by date.AVBP ebit by date.
-8.696M-36.906M
-324.40%		-74.59M
-102.11%		N/A
-34.40%		N/A
-21.98%		N/A
-16.58%		N/A
65.37%		N/A
122.11%		N/A
751.40%		N/A
67.18%		N/A
42.35%		N/A
20.29%
Operating Margin
AVBP operating margin by date.AVBP operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
AVBP eps by date.AVBP eps by date.
N/AN/AN/AN/A
70.20%		N/A
-20.36%		N/A
-13.92%		N/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.79-0.81
-15.11%		-0.86
-31.82%		-0.90
-47.15%		-0.93
-17.12%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-26.83MN/AN/AN/AN/A
EBIT
Q2Q % growth		-27.728M
-19.94%		-30.114M
-45.66%		-31.718M
-23.43%		-32.639M
-34.69%		-33.724M
-21.63%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.61 -1.020.4140.25%
Q2 2024
Q2Q % growth		 -0.65 -0.660.010.94%
Q1 2024
Q2Q % growth		 -0.70 -1.120.4237.46%
AVBP Yearly EPS VS EstimatesAVBP Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -2 -4 -6 -8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
AVBP Yearly Revenue VS EstimatesAVBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS25.62% 28.8% 0% 15.53%
RevenueN/A N/A N/A N/A